Organic Active Ingredients TRIZ Cases

Molecular glue compounds bridge cereblon and CDK2 to induce targeted protein ubiquitination, solving inadequate specificity in existing cancer therapies.

Sanguinarine elevates reactive oxygen species to degrade EGFR, overcoming steric hindrance from the T790M mutation.

Anti-microRNA compositions upregulate TULA-2 to inhibit platelet activation, avoiding serious bleeding risks associated with conventional thrombosis treatments.

Coexisting stabilizers suppress diclofenac lactam generation in hyaluronic acid compositions, preserving therapeutic efficacy during storage.

Recombinant vectors express cancer antigens for non-invasive detection, resolving the trade-off between diagnostic sensitivity and procedural complexity.

Transient Runx1-CBFβ inhibitor treatment induces hematopoietic stem cell specification from progenitor cells.

Formula I compounds competitively bind the EGFR kinase ATP site, inhibiting proliferation of cells resistant to first-line therapies like erlotinib.

Incorporating 1% to 4.5% (R)-nicotine into aerosol formulations reduces throat irritation and improves sensory effects without altering manufacturing processes.

Chewing gum composition delivers cannabinoids via oral mucosa absorption, eliminating respiratory harm from combustion.

Antisense oligonucleotides induce exon skipping in immunoglobulin transcripts, producing truncated proteins that trigger apoptosis in cancerous plasma cells.

Azaindazole compounds antagonize Wnt pathway activity to treat cancers and fibrotic disorders caused by aberrant signaling.

Subcutaneous triamcinolone injection induces targeted fat cell atrophy, avoiding surgical risks and systemic side effects.

Co-solvent evaporation with surface-active excipients resolves poor aerosolization by mediating water-insoluble active agent dispersion.

Dissolving active agents in liquid vehicles inside soft gel capsules improves bioavailability while reducing side effects from high-dose administration.

Needle-free intranasal naloxone delivery eliminates injection risks while achieving reliable blood levels through optimized pH formulation.

A flurbiprofen orally-disintegrating tablet formulation uses a graft copolymer to achieve rapid disintegration.

Irreversible acrylamide warheads on quinazoline cores overcome T790M drug resistance by blocking EGFR signal transduction.

Replacing gelatin with polysaccharide derivatives eliminates heat sensitivity while the hygroscopic solvent maintains moisture balance for stable drug delivery.

CB2 receptor antagonists reverse endocannabinoid-induced T cell suppression, restoring antitumor immune responses and inhibiting cancer cell proliferation.

Segmented genetic circuits use universal regulatory elements to resolve the trade-off between detection sensitivity and structural complexity.

Spray-dried ibrutinib solid dispersions disperse the drug in a polymer matrix, reducing pharmacokinetic variability compared to traditional capsules.

Antioxidant-stabilized micronized granules preserve Syk/JAK inhibitor purity during open container storage.

Truncated RNA aptamers inhibit NGF receptor binding without triggering immune reactions associated with antibody therapies.

Imidazopyrazine compounds inhibit Syk enzymatic activity, reducing B-cell activation and side effects in autoimmune diseases.

Sulphamoylpyrrolamide derivatives inhibit hepatitis B virus replication while reducing toxicity and improving bioavailability compared to existing antivirals.

Self-assembled rosette nanotubes protect small RNA from serum degradation while enabling efficient cellular uptake through endocytosis.

Specific 2-hydroxy-1-{4-[(4-phenylphenyl)carbonyl]piperazin-1-yl}ethan-1-one derivatives inhibit fatty acid synthase activity.

Heterocyclic compounds inhibit JAK1 kinase activity through specific molecular binding, reducing toxicity from non-selective inhibition.

3-substituted amino-2-arylpyrrolo[2,3-c]pyridine compounds overcome drug resistance in cancer cells by inhibiting protein kinase CK2.

Antisense oligonucleotides hybridize to utrophin mRNA binding sites to boost protein levels in muscle cells.

Anti-IL-5 antibodies achieve defined plasma concentrations to suppress eosinophil production, avoiding corticosteroid side effects.

N2-modified guanine bases stabilize G-quadruplex nanoparticles, resolving the contradiction between structural integrity and functional versatility.

Water-soluble prodrug and enzyme system bypasses solubility limits, enabling rapid intranasal absorption without organic excipients.

A self-nanoemulsifying formulation disperses poorly soluble drugs into nanoemulsions upon aqueous exposure.

A tissue culture media matrix supports human pancreatic islet survival and engraftment.

Galactose increases serpin production in Bifidobacterium longum to treat celiac disease without GMO regulatory hurdles.

Computational docking optimizes substituted imidazopyridines to inhibit ENPP1, resolving the trade-off between treatment efficacy and adverse side effects.

Liposomes in a continuous hydrophobic phase deliver antigens to induce long-lasting cytotoxic T lymphocyte responses, preventing tumor recurrence.

Carrier-free nanoparticles stabilized with a native albumin layer provide improved circulation stability and targeted cell interaction.

A polyethylene glycol conjugate with local anesthetics creates a sustained release system for extended pain relief.

Arginine and antioxidants stabilize pemetrexed in liquid form, preventing oxidative degradation without freeze drying.

FR-targeting agents deliver antigens to first responder dendritic cells using TLR agonists, resolving low targeting precision in vaccine development.

Neoandrographolide lowers blood glucose and lipid levels while protecting liver and renal function in a single pharmaceutical composition.

A plant extract containing concentrated diketopiperazines forms through thermal processing of protein sources.

Allosteric pyrimidine compounds selectively modulate gamma secretase to lower amyloid beta while preserving notch signaling integrity.

A siRNA sequence targets the conserved signal peptide region of the viral S protein to suppress expression.

A compound binds STRAD pseudokinase to stabilize and activate the LKB1 kinase.

Targeting intelectin-1 resolves toxic side-effects from broad mucolytics by reducing mucus viscosity and enhancing muco-ciliary clearance.

Composite prosthetic patches with covalently bound drug-loaded particles deliver therapeutic agents locally.

Autologous plasmacytoid dendritic cells expand in vitro to promote hair growth, avoiding long-term drug side effects.

Dimethylfasudil inhibits Rho-associated protein kinase activity to destroy cancer cells with high MYC expression.

Optimized lysophospholipid ratios in liposomes resolve the trade-off between sustained exposure time and drug leakage rate.

Combines dendritic cell vaccines with myeloid-derived suppressor cell inhibitors to activate immune responses against tumors.

New solid crystalline forms of helicase-primase inhibitors enhance solubility and bioavailability for antiviral applications.

Oligosaccharide blends enhance cognitive development by supporting GABAergic activity to address neurodevelopmental gaps.

Targeted RNAi therapy reduces angiotensinogen levels, improving hypertension management while preserving kidney function.

A nebulizing nozzle with multiple ejection channels generates aerosolized pirfenidone through intersecting liquid streams.

Segmented carboxamide structures modulate epigenetic regulation to address inadequate therapeutic efficacy in treating proliferative disorders.

Co-administering etrasimod with hormone therapies treats S1P1 disorders while preserving hormonal efficacy and minimizing pharmacokinetic changes.

Defined amino acid composition modifies traumatic brain injury symptoms through precise leucine, isoleucine, and valine ratios.

Combining vericiguat and finerenone activates soluble guanylate cyclase while blocking mineralocorticoid receptors.

A bipotent cell population self-assembles into functional vascular networks through spontaneous organization and differentiation.

Carbohydrates and pH buffers stabilize freeze-dried vinca alkaloids, eliminating refrigeration needs.

Controlled suspension processes yield stable intedanib methanesulfonate polymorphs that resolve bioavailability and manufacturability trade-offs.

Merging peptide epoxyketone proteasome and PIM kinase inhibitors reduces toxic side effects while enhancing treatment efficacy against refractory cancers.

Composite lipid structures prevent particle aggregation during storage while enabling efficient nucleic acid release into the cytoplasm.

A polycyclic compound inhibits Cbl-b activity to modulate immune responses.

Wnt pathway activators counteract thalidomide teratogenicity by blocking Bmp/Dkk1 signaling to prevent limb defects.

A sphingosine-1-phosphate receptor agonist inhibits hematological malignancy recurrence in stem cell transplant patients.

Enzymatic hydrolysis isolates high-purity EPA from microalgae polar lipids, bypassing inefficient fish oil purification and reducing unwanted DHA contamination.

Removing buffer additives from the hydromorphone hydrochloride formulation eliminates toxicity risks while maintaining stable pH levels.

Integrating fenbendazole into specific grain carriers protects the drug from environmental degradation while reducing nematode burdens in wild birds.

A synergistic composition combining N-1-methyl nicotinamide and red spinach extract enhances vascular health through dual mediator pathways.

Lipid-like moieties resist enzyme-mediated ω-oxidation to improve metabolic stability and reduce nephrotoxicity.

Specific ATR kinase inhibitor compounds target DNA repair pathways in malignant cells.

Pre-filled syringes deliver sterile baclofen solutions with color-coded concentration markers for immediate clinical use.

Hyperbranched polyglycerol polyglycidyl ether crosslinks polysaccharides to resolve toxicity and mechanical instability trade-offs in therapeutic applications.

Targeting ALK5 and ACVR2A receptors overcomes functional redundancy that limits single-receptor inhibition, increasing bone mineral density.

Ester derivatives modify buprenorphine to improve oral bioavailability and reduce misuse risk while maintaining therapeutic efficacy.

Novel indolizine derivatives antagonize fibroblast growth factor receptor binding through precise structural optimization.

Formula I compounds relax airway smooth muscles to reduce constriction without organ toxicity.

A meloxicam inclusion complex with sulfobutyl ether beta-cyclodextrin accelerates drug absorption.

Positionable magnetic filtration devices capture therapeutic agents conjugated to magnetic particles within blood vessels.

Conjugated modified oligonucleotides inhibit miR-122 to reduce HCV RNA levels and prevent resistance.

Selective heteroaromatic inhibitors target PKMYT1 to resolve toxicity contradictions in advanced solid tumor therapy.

Substituted benzene compounds inhibit EZH2 histone methyltransferase activity to prevent H3-K27 trimethylation and control cancer cell proliferation.

Soluble guanylate cyclase stimulators target the NO/cGMP pathway to inhibit fibrotic processes in systemic sclerosis models.

A nonaqueous carbon dioxide external preparation generates gas upon water absorption.

Merges Garcinia cambogia and Acanthopanax extracts to reduce liver tissue fat accumulation and LDL levels while inhibiting FAS mRNA expression.